These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9291436)

  • 1. Soluble CD44 splice variants in metastasizing human breast cancer.
    Martin S; Jansen F; Bokelmann J; Kolb H
    Int J Cancer; 1997 Aug; 74(4):443-5. PubMed ID: 9291436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble CD44 v5 and v6 in serum of patients with breast cancer. Correlation with expression of CD44 v5 and v6 variants in primary tumors and location of distant metastasis.
    Lackner C; Moser R; Bauernhofer T; Wilders-Truschnig M; Samonigg H; Berghold A; Zatloukal K
    Breast Cancer Res Treat; 1998 Jan; 47(1):29-40. PubMed ID: 9493973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum assay of soluble CD44 standard (sCD44-st), CD44 splice variant v5 (sCD44-v5), and CD44 splice variant v6 (sCD44-v6) in patients with epithelial ovarian cancer.
    Gadducci A; Ferdeghini M; Fanucchi A; Annicchiarico C; Cosio S; Prontera C; Bianchi R; Genazzani AR
    Anticancer Res; 1997; 17(6D):4463-6. PubMed ID: 9494551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased soluble CD44 concentrations are associated with larger tumor size and lymph node metastasis in breast cancer patients.
    Mayer S; zur Hausen A; Watermann DO; Stamm S; Jäger M; Gitsch G; Stickeler E
    J Cancer Res Clin Oncol; 2008 Nov; 134(11):1229-35. PubMed ID: 18438684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble CD44 splice variants and pelvic lymph node metastasis in ovarian cancer patients.
    Stickeler E; Vogl FD; Denkinger T; Mobus VJ; Kreienberg R; Runnebaum IB
    Int J Mol Med; 2000 Nov; 6(5):595-601. PubMed ID: 11029531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human mammary carcinomas express homologues of rat metastasis-associated variants of CD44.
    Sinn HP; Heider KH; Skroch-Angel P; von Minckwitz G; Kaufmann M; Herrlich P; Ponta H
    Breast Cancer Res Treat; 1995; 36(3):307-313. PubMed ID: 8573713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD44 expression patterns in breast and colon tumors: a PCR-based study of splice variants.
    Rodriguez C; Monges G; Rouanet P; Dutrillaux B; Lefrançois D; Theillet C
    Int J Cancer; 1995 Oct; 64(5):347-54. PubMed ID: 7591309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated serum levels of soluble CD44 variant 6 are correlated with shorter survival in aggressive non-Hodgkin's lymphoma.
    Sasaki K; Niitsu N
    Eur J Haematol; 2000 Sep; 65(3):195-202. PubMed ID: 11007056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The serum assay of soluble CD44 standard (sCD44-st), CD44 splice variant 5 (sCD44-v5), and CD44 splice variant 6 (sCD44-v6) in patients with cervical cancer.
    Gadducci A; Ferdeghini M; Cosio S; Annicchiarico C; Fanucchi A; Prontera C; Bianchi R; Genazzani AR
    Anticancer Res; 1998; 18(1B):537-9. PubMed ID: 9568174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD44 isoforms with exon v6 and metastasis of primary N0M0 breast carcinomas.
    Guriec N; Gairard B; Marcellin L; Wilk A; Caldéroli H; Renaud R; Bergerat JP; Oberling F
    Breast Cancer Res Treat; 1997 Jul; 44(3):261-8. PubMed ID: 9266106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoform expression of CD44 adhesion molecules, Bcl-2, p53 and Ki-67 proteins in lung cancer.
    Mizera-Nyczak E; Dyszkiewicz W; Heider KH; Zeromski J
    Tumour Biol; 2001; 22(1):45-53. PubMed ID: 11054026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble CD44 isoforms in serum as potential markers of metastatic gastric carcinoma.
    Harn HJ; Ho LI; Shyu RY; Yuan JS; Lin FG; Young TH; Liu CA; Tang HS; Lee WH
    J Clin Gastroenterol; 1996 Mar; 22(2):107-10. PubMed ID: 8742647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD44 variant exon epitopes in primary breast cancer and length of survival.
    Kaufmann M; Heider KH; Sinn HP; von Minckwitz G; Ponta H; Herrlich P
    Lancet; 1995 Mar; 345(8950):615-9. PubMed ID: 7534855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levels of v5 and v6 CD44 splice variants in serum of patients with colorectal cancer are not correlated with pT stage, histopathological grade of malignancy and clinical features.
    Zalewski B
    World J Gastroenterol; 2004 Feb; 10(4):583-5. PubMed ID: 14966921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression of variant exon v7-v8 CD44 antigen in relation to lymphatic metastasis of human breast cancer.
    Kinoshita J; Haga S; Shimizu T; Imamura H; Watanabe O; Kajiwara T
    Breast Cancer Res Treat; 1999 Jan; 53(2):177-83. PubMed ID: 10326795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of soluble CD44 in patients with breast and colorectal carcinomas and non-Hodgkin's lymphoma.
    Lockhart MS; Waldner C; Mongini C; Gravisaco MJ; Casanova S; Alvarez E; Hajos S
    Oncol Rep; 1999; 6(5):1129-33. PubMed ID: 10425314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of CD44 and the pattern of CD44 alternative splicing in uveal melanoma.
    Danen EH; ten Berge PJ; van Muijen GN; Jager MJ; Ruiter DJ
    Melanoma Res; 1996 Feb; 6(1):31-5. PubMed ID: 8640067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of CD44 variants in gastric carcinoma with or without Epstein-Barr virus.
    Chong JM; Fukayama M; Hayashi Y; Funata N; Takizawa T; Koike M; Muraoka M; Kikuchi-Yanoshita R; Miyaki M; Mizuno S
    Int J Cancer; 1997 Aug; 74(4):450-4. PubMed ID: 9291438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of CD44 splice variants in human stage III cervical cancer.
    Kainz C; Kohlberger P; Tempfer C; Sliutz G; Gitsch G; Reinthaller A; Breitenecker G
    Eur J Cancer; 1995 Sep; 31A(10):1706-9. PubMed ID: 7488429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of CD44 standard and isoforms in human breast cancer xenografts and shedding of soluble forms into serum of nude mice.
    Fichtner I; Dehmel A; Naundorf H; Finke LH
    Anticancer Res; 1997; 17(5A):3633-45. PubMed ID: 9413216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.